Related Experiment Videos
Community-acquired bacteraemic Acinetobacter pneumonia with survival
Postgraduate Medical Journal
|December 1, 1993
Summary
A rare bacterial cause of community-acquired pneumonia, Acinetobacter calcoaceticus, can be fatal. Prompt antibiotic treatment led to a patient's recovery from severe lung infection.
Area of Science:
- Infectious Diseases
- Pulmonology
- Microbiology
Background:
- Community-acquired pneumonia (CAP) is a common infection, but certain bacterial pathogens remain rare and challenging to treat.
- Acinetobacter species are increasingly recognized as nosocomial pathogens, but their role in CAP is less understood.
Observation:
- A 65-year-old man presented with severe pneumonia and rapid deterioration despite standard antibiotic therapy.
- The patient required mechanical ventilation due to respiratory failure.
- Acinetobacter calcoaceticus var. anitratus was identified in sputum and blood cultures.
Findings:
- The patient received a combination therapy including an anti-pseudomonal agent, aminoglycoside, and cotrimoxazole.
- Acinetobacter calcoaceticus var. anitratus was susceptible to the prescribed antibiotic regimen.
- The patient experienced a slow but significant recovery from the severe pneumonia.
Implications:
- This case highlights Acinetobacter calcoaceticus as a rare but potentially fatal cause of community-acquired pneumonia.
- Effective antibiotic selection is crucial for managing severe Acinetobacter infections.
- Further research is needed to understand the epidemiology and optimal treatment strategies for Acinetobacter-related CAP.